REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amgen, Inc. (NQ: AMGN)
105.42 USD  -0.20 (-0.19%)
Streaming Delayed Price  /  Updated: 10:56 AM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Amgen, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
84 85 Next >
Trials of Amgen's (AMGN) Sensipar Halted Following Death - FDA
February 26, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8133403 for the full story. Read More
from StreetInsider.com News Articles
Guggenheim Raises Price Target on Amgen (AMGN)
February 26, 2013
Guggenheim reported on Tuesday that they have increased their price target on biotechnology medicines company, Amgen, Inc.(AMGN). The firm, which currently has a “Neutral” rating on AMGN, has raised... Read More
category amgen , amgn , Dividend Stocks
from Dividend Daily
Market Wrap: Was Chesapeake Undercut by Sinopec?; RP Management Bids for Elan; BlackBerry's Shocking Sales
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8130395 for the full story. Read More
from StreetInsider.com News Articles
Dividend Highlights/Lowlights for Feb. 25
February 25, 2013
These were some of the biggest dividend stock performers on the upside and the downside in today’s market action. Highlights Amgen (AMGN) – up 3% Icahn Enterprises L.P. (IEP) – up 2% Staples (SPLS) –... Read More
category vz , mcd , chk , and 10 more.
from Dividend Daily
Market Wrap for Monday, February 25: Stocks Plunge on Italy Fears
February 25, 2013
The U.S. stock market was hit hard on Monday as investors reacted to uncertainty emanating out of Italy on election day. The Dow lost more than 200 points on fears that a divided Italian parliament... Read More
category ZNGA , Benzinga , Movers , and 17 more.
from Latest Articles from Benzinga.com
Market Wrap-Up for Feb.25 (MJN, AMGN, AAPL, DRI, PETM, CMI, more)
February 25, 2013
The markets saw quite a bit of volatility pick up as all eyes appear to be on the elections being held in Italy. After a nice pop at the open, the averages pulled back hard with some decent momentum as... Read More
category cme , ip , amgn , and 9 more.
from Dividend Daily
Chart of the Day: Amgen Hits All-Time High
February 25, 2013
Amgen (NASDAQ:AMGN) broke out to an all-time high today which is quite a feat for a $70 billion market cap biotechnology company that has had numerous strong rallies over the past 20 years. Amgen is... Read More
from Minyanville Headlines
US STOCKS SNAPSHOT-Major U.S. stock indexes hit session lows
February 25, 2013
NEW YORK, Feb 25 (Reuters) - U.S. stocks extend losses with major indexes hitting session lows by late afternoon trade on Monday on fears that a divided parliament in Italy would get in the way of the... Read More
category companyNews
from Reuters: Company News
Affymax Crushed After Fatal Drug Recalled; Bleeding Cash, The Company Could Be Done For
February 25, 2013
Shares in pharma company Affymax are down more than 80% on Monday after the company recalled its anemia drug Omontys on reports of a lethal allergic reaction that has already caused three deaths,... Read More
category NYSE:MRK , NYSE:SNY , NYSE:PFE , and 2 more.
from Forbes Real Time
Notable 52-Week Highs and Lows of the Day 02/25: (HTZ) (AMGN) (UAL) High; (AFFY) (DVAX) (CLSN) Low
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8129053 for the full story. Read More
from StreetInsider.com News Articles
US STOCKS-Dow, S&P slip after uncertain Italian election
February 25, 2013
* Divided government in Rome could hinder euro-zone reform Read More
category companyNews
from Reuters: Company News
Affymax plunges 85% on recall of anemia drug
February 25, 2013
Shares of Affymax plummet after the company recalls an anemia drug that caused several fatalities. Read More
category Computer Software , Biotechnology , Financial Services , and 21 more.
from MarketWatch
US STOCKS-Wall St dips on uncertain Italian election
February 25, 2013
* Divided government in Rome could hinder euro zone reform Read More
category companyNews
from Reuters: Company News
US STOCKS-Wall St rallies on growth optimism
February 25, 2013
* Barnes & Noble rallies on report part of it may go private Read More
category companyNews
from Reuters: Company News
UPDATE: Bank of America Raises PO to $99 on Amgen After Omontys Recall
February 25, 2013
In a report published Monday, Bank of America reiterated a Neutral rating on Amgen (NASDAQ: AMGN ), and raised its price objective from $97 to $99. Bank of America wrote, "This weekend, AFFY/Takeda... Read More
category Benzinga , Bank of America , AMGN , and 3 more.
from Latest Articles from Benzinga.com
Amgen (AMGN) Ramps on Major Affymax Setback
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8128215 for the full story. Read More
from StreetInsider.com News Articles
Amgen (AMGN) Says Keeping Oral-Only Drugs on Medicare Pt. D Would Produce 'Significant' Savings
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8128112 for the full story. Read More
from StreetInsider.com News Articles
Blood Drug Woes Could Weigh on FDA and its Approval of New, Copycat Biologic Medicines
February 25, 2013
The announcement last night that Affymax (NASDAQ: AFFY) is recalling all lots of its red blood cell stimulating medicine Omontys could have broader implications for how the Food and Drug Administration... Read More
category NASDAQ:AFFY , NASDAQ:AMGN
from Forbes Real Time
Trading Alert for Amgen (AMGN)
February 25, 2013
NEW YORK (AVAFIN) -- Amgen options contracts experienced a new 90-day record for call ... Read More
from AVAFIN
Benzinga's Small Cap Movers for Thursday February 21, 2013
February 21, 2013
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: CombiMatrix Shares of CombiMatrix (NASDAQ: CBMX ), the Irvine, CA molecular diagnostics company, rose 136%... Read More
category Rumors , Benzinga , Movers , and 12 more.
from Latest Articles from Benzinga.com
Watch for Shares of Amgen (AMGN) to Approach Resistance at $85.12
February 20, 2013
from Comtex SmarTrend® News Briefs
There's Nothing Contradictory About Amgen's Biosimilars Move
February 19, 2013
There have been comments in some quarters that Amgen's move into making its own biosimilars -- the biotech version of generics -- is somehow self-contradictory. Up until this announcement, Amgen has... Read More
category NASDAQ:AMGN
from Forbes Real Time
Sell and Sell Aggressively, Says Carter Worth
February 19, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8111373 for the full story. Read More
from StreetInsider.com News Articles
Week in Review: Amgen to Build China Presence with Partnerships/M&A
February 16, 2013
Amgen is planning to increase its participation in the China market, using a combination of partnerships and M&A to build a presence; China Shenghuo Pharma received a proposal from its majority owner... Read More
from ChinaBio® Today
Sangamo Biosciences, Smart Emerging Growth Option in the Medical Research Sector
February 15, 2013
category Advisory , Research Analysis and Reports , MEDICAL , and 4 more.
from Latest eTeligis Press Releases with 'Plus' ranking
After Stock Plunges, Maybe Affymax News Isn't So Bad?
February 14, 2013
Investors didn’t like the news from drug maker Affymax (NASDAQ:AFFY) Thursday morning. The company’s pilot program for the injected treatment Omontys in kidney failure patients won’t be expanded at one... Read More
from Minyanville Headlines
Amgen will Use Partnerships and M&A to Enter China Market
February 14, 2013
Amgen is planning a China market initiative, using a combination of partnerships and M&A to gain a foothold. It expects to have its own patented drugs on the China market by 2015. At the same time, the... Read More
from ChinaBio® Today
Notable ETF Outflow Detected - IWV, MMM, AMGN, BMY
February 13, 2013
Symbols mentioned in this story: IWV, MMM, AMGN, BMY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)
February 12, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed again in the latter two weeks of January. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA ),... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
William Blair Downgrades Amgen to “Market Perform” (AMGN)
February 12, 2013
Biotech giant Amgen, Inc. (AMGN) was downgraded by analysts at William Blair on Tuesday, as the company may be in store for a transitional year in 2013. The analysts downgraded AMGN from “Outperform”... Read More
category amgn , amgen inc , Dividend Stocks
from Dividend Daily
< Previous 1 2 3 4 5 6 7 8 9
...
84 85 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here